Efficacy and safety of switching from boosted lopinavir to boosted atazanavir in patients with virological suppression receiving a lpv/r-containing haart: The atazip study

  1. Mallolas, J.
  2. Podzamczer, D.
  3. Milinkovic, A.
  4. Domingo, P.
  5. Clotet, B.
  6. Ribera, E.
  7. Gutiérrez, F.
  8. Knobel, H.
  9. Cosin, J.
  10. Ferrer, E.
  11. Arranz, J.A.
  12. Roca, V.
  13. Vidal, F.
  14. Murillas, J.
  15. Pich, J.
  16. Pedrol, E.
  17. Llibre, J.M.
  18. Dalmau, D.
  19. García, I.
  20. Aranda, M.
  21. Cruceta, A.
  22. Martínez, E.
  23. Blanco, J.L.
  24. Lazzari, E.D.
  25. Gatell, J.M.
Revue:
Journal of Acquired Immune Deficiency Syndromes

ISSN: 1525-4135

Année de publication: 2009

Volumen: 51

Número: 1

Pages: 29-36

Type: Article

DOI: 10.1097/QAI.0B013E31819A226F GOOGLE SCHOLAR